Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib

J Thorac Oncol. 2019 May;14(5):e95-e96. doi: 10.1016/j.jtho.2018.12.036.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Mutation
  • Organophosphorus Compounds / pharmacology
  • Organophosphorus Compounds / therapeutic use*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Sulfones / pharmacology
  • Sulfones / therapeutic use*

Substances

  • Organophosphorus Compounds
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfones
  • brigatinib
  • ceritinib